Release Date: 04/02/10 10:41 Summary: Sebree Reserves Report Completed Price Sensitive: Yes Download Document 15.19MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%